The Role of Omega-3 Polyunsaturated Fatty Acids in Patients with Metabolic Syndrome and Endothelial Dysfunction.

Andrej Dzupina, Dominik Pella, Pavol Zenuch, Zuzana Zenuchova, Jaipaul Singh, Monika Jankajova, Jan Fedacko

Abstract readRandomized Controlled Trial

In one paragraph

Trial report in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Omega-3 Polyunsaturated Fatty Acids Effect on Neuropathy of the Peripheral Nervous System in Dietary Obese Rats: Is the Source of These Fatty Acids Important for Outcome?Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
Article
Impact of Modern Oven Treatments on Lipid Oxidation and Vitamin E Content of Fillets from Sardine (Antioxidants (Basel, Switzerland) · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrej DzupinaDepartment of Angiology, National Heart Institute, 040 11 Bratislava, Slovakia.

Dominik PellaCentre of Clnical and Preclinical Research, MEDIPARK-University Research Park, Pavol Jozef Safarik University, Trieda SNP 1, 040 11 Kosice, Slovakia.

Pavol ZenuchCentre of Clnical and Preclinical Research, MEDIPARK-University Research Park, Pavol Jozef Safarik University, Trieda SNP 1, 040 11 Kosice, Slovakia.

Zuzana ZenuchovaCentre of Clnical and Preclinical Research, MEDIPARK-University Research Park, Pavol Jozef Safarik University, Trieda SNP 1, 040 11 Kosice, Slovakia.

Jaipaul SinghSchool of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.

Monika JankajovaKardiocentrum AGEL SACA, Lúčna 57/040 15, 040 15 Košice, Slovakia.

Jan FedackoCentre of Clnical and Preclinical Research, MEDIPARK-University Research Park, Pavol Jozef Safarik University, Trieda SNP 1, 040 11 Kosice, Slovakia.ORCID 0000-0002-4940-0393

Funding

Operational Program Integrated Infrastructure, co-founded by European Regional Development Fund ITMS: 313011AUB1

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endothelium, VascularFatty Acids, Omega-3Metabolic SyndromeAdultDietary SupplementsFemaleHomocysteineHumansMaleMiddle AgedFatty Acids, Omega-3Homocysteineendothelial dysfunctionheart diseasesmetabolic syndromeomega-3 fatty acids

Identifiers

PMID39859026

DOI10.3390/medicina61010043

PMCPMC11766591

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.